[1]Qiao PG, Han C, Qian T, et al. BOLD-fMRI with median nerve electrical stimulation predict hemodynamic improvement after revascularization in patients with moyamoya disease[J]. J Magn Reson Imaging, 2017, 46(4): 1159-1166.
[2]Kazumata K, Tha KK, Uchino H, et al. Mapping altered brain connectivity and its clinical associations in adult moyamoya disease: A resting-state functional MRI study[J]. PLoS One, 2017, 12(8): e0182759.
[3]Lei Y, Song B, Chen L, et al. Reconfigured functional network dynamics in adult moyamoya disease: a resting-state fMRI study[J]. Brain Imaging Behav, 2020, 14(3): 715-727.
[4]Noh HJ, Kim SJ, Kim JS, et al. Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease[J]. J Neurol Sci, 2015, 359(1-2): 381-388.
[5]Kazumata K, Tokairin K, Ito M, et al. Combined structural and diffusion tensor imaging detection of ischemic injury in moyamoya disease: relation to disease advancement and cerebral hypoperfusion[J]. J Neurosurg, 2020, 134(3): 1155-1164.
[6]Zhao M, Deng X, Zhang D, et al. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease[J]. J Neurosurg, 2018: 1-12.
[7]Ge P, Zhang Q, Ye X, et al. Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease[J]. World Neurosurg, 2017, 100: 459-466.
[8]Kim M, Park W, Chung Y, et al. Development and validation of a risk scoring model for postoperative adult moyamoya disease[J]. J Neurosurg, 2020, 134(5): 1505-1514.
[9]Kang S, Liu X, Zhang D, et al. Natural Course of Moyamoya Disease in Patients With Prior Hemorrhagic Stroke[J]. Stroke, 2019, 50(5): 1060-1066.
[10]Zhao M, Deng X, Gao F, et al. Ischemic Stroke in Young Adults with Moyamoya Disease: Prognostic Factors for Stroke Recurrence and Functional Outcome after Revascularization[J]. World Neurosurg, 2017, 103: 161-167.